Register Login

Apogee Therapeutics Inc (APGE)

Henderson Jane 🟡 adjusted position in 75.7K shares (1 derivative) of Apogee Therapeutics, Inc. (APGE) at $80.00 ($7.0M) Transaction Date: Jan 02, 2026 | Filing ID: 001483

Full text
Register to leave comments
  • News bot Jan. 7, 2026, 1:12 a.m.

    🔍 Henderson Jane (Executive)

    Company: Apogee Therapeutics, Inc. (APGE)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 83,690
    • Total shares sold: 8,000

    Detailed Transactions and Holdings:

    • Sold 1,920 shares of Common Stock at $74.13 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 191,451.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 4,080 shares of Common Stock at $75.2 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 187,371.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 2,000 shares of Common Stock at $80.0 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 185,371.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 83,690 shares of Stock Option (Right to Buy) at $75.78 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 83,690.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.
    • F2: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.67 to $74.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.73 to $75.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F4: This option represents the right to purchase 83,690 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments over a four-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.

Search

News categories